Caricamento...
Dendritic Cell-Induced Th1 and Th17 Cell Differentiation for Cancer Therapy
The success of cellular immunotherapies against cancer requires the generation of activated CD4(+) and CD8(+) T-cells. The type of T-cell response generated (e.g., Th1 or Th2) will determine the efficacy of the therapy, and it is generally assumed that a type-1 response is needed for optimal cancer...
Salvato in:
| Pubblicato in: | Vaccines (Basel) |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
MDPI
2013
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4494209/ https://ncbi.nlm.nih.gov/pubmed/26344346 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines1040527 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|